|
ABL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.011600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.860000E-01 |
| Normal-vs-Stage2 |
1.554240E-01 |
| Normal-vs-Stage3 |
4.684200E-01 |
| Normal-vs-Stage4 |
4.599400E-01 |
| Stage1-vs-Stage2 |
3.737700E-02 |
| Stage1-vs-Stage3 |
6.372000E-01 |
| Stage1-vs-Stage4 |
6.563600E-01 |
| Stage2-vs-Stage3 |
4.611900E-02 |
| Stage2-vs-Stage4 |
3.955700E-02 |
| Stage3-vs-Stage4 |
9.406400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.174400E-01 |
| Normal-vs-AfricanAmerican |
3.460400E-02 |
| Normal-vs-Asian |
3.892800E-01 |
| Caucasian-vs-AfricanAmerican |
1.528210E-01 |
| Caucasian-vs-Asian |
4.268500E-02 |
| AfricanAmerican-vs-Asian |
6.255300E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.108800E-01 |
| Normal-vs-Female |
7.984400E-01 |
| Male-vs-Female |
7.134000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.798570E-01 |
| Normal-vs-Age(41-60Yrs) |
6.829000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.095400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.803800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.658200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.592300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.887400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.863800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.252000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.263800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.873000E-01 |
| Classical-VS-Follicular |
2.5640600753718E-12 |
| Classical-VS-Other |
1.460970E-01 |
| Classical-VS-Normal |
7.772500E-02 |
| Tall-VS-Follicular |
1.93392999999764E-05 |
| Tall-VS-Other |
9.338000E-02 |
| Tall-VS-Normal |
2.593400E-01 |
| Follicular-VS-Other |
5.386200E-01 |
| Follicular-VS-Normal |
4.571200E-04 |
| Other-VS-Normal |
3.101400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.503760E-01 |
| Normal-vs-N1 |
5.092800E-01 |
| N0-vs-N1 |
2.391700E-02 |
|
|
